BIOEMTECH

About BIOEMTECH

BIOEMTECH is a Other / Uncategorized company; the kind of vendor BD teams should have a 15-minute conversation with at SNMMI.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• STAT News · 2026-12-01
  Bioemtech partners with academic center on Actinium-225 program
  Coverage notes the company's growing footprint in the radioligand therapy space.
• Imaging Wire · 2026-11-06
  Bioemtech files IND for next-generation PSMA-targeted agent
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• PR Newswire · 2026-10-03
  Bioemtech publishes dosimetry data at SNMMI 2026
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• Nuclear Medicine Today · 2026-05-20
  Bioemtech closes Series C round to scale radiopharma manufacturing
  The announcement comes amid tightening Mo-99 and Lu-177 supply.
• Endpoints News · 2026-12-01
  Bioemtech signs supply agreement to support late-stage trials
  The announcement comes amid tightening Mo-99 and Lu-177 supply.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.